Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

for
Breast Cancer, Metastatic Gastric Cancer, Esophageal Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: Female

Age: 18+

Code: NCT05183126

Recruiting

GammaPod Dose Escalation Radiation for Early Stage Breast Cancer

for
Breast Cancer
Location: Bel Air MD, Glen Burnie MD, Baltimore MD, Columbia MD
Sponsor: University of Maryland, Baltimore

Sex: Female

Age: 45+

Code: NCT04234386

Recruiting

Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)

for
Breast Cancer
Location: Charlestown MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 30 - 70+

Code: NCT02033486

Recruiting

Psychological Benefits of a Normalized Camping Experience for Children With Cancer

for
Pediatric Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 7 - 25

Code: NCT00001186

Recruiting

Feasibility/Acceptability of Attentional-Control Training in Survivors

for
Pediatric Cancer, Pediatric ALL, Pediatric Brain Tumor,
Location: Washington DC
Sponsor: Children's National Research Institute

Sex: All

Age: 8 - 16

Code: NCT05528939

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

for
Malignant Brain Neoplasm, Malignant Solid Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT06788886

Recruiting

Telemonitoring Hypertension and Breast Cancer

for
Hypertension, Breast Cancer
Location: Jackson MS
Sponsor: University of Mississippi Medical Center

Sex: Female

Age: 18+

Code: NCT05574686

Recruiting

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

for
Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT06115486

Recruiting

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

for
Breast Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT04965064

Phase 2, Recruiting

Breast Cancer Survivorship Biorepository

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: Female

Age: 18+

Code: NCT05786664

Recruiting

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06302621

Phase 1, Recruiting

The Immune System's Response to Young Women's Breast Cancer

for
Breast Cancer, Breast Cancer and Pregnancy
Location: Lone Tree CO, Denver CO, Aurora CO, Highlands Ranch CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 18+

Code: NCT01503190

Recruiting

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

for
Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer
Location: Skokie IL
Sponsor: Guardant Health, Inc.

Sex: All

Age: 18+

Code: NCT05935384

Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Morristown NJ, Jacksonville FL, Chicago IL,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

for
Autoimmune Diseases, Cardiovascular Disorders,
Location: Culver City CA
Sponsor: Thomas Advanced Medical LLC

Sex: All

Age: 18+

Code: NCT04684602

Phase 1, Phase 2, Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Salt Lake City UT,
Sponsor: Peel Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05329103

Phase 1, Recruiting

Physical Activity Levels and Functional Improvement in Breast Cancer Survivors

for
Breast Cancer
Location: St. John's, Charlottetown, Fredericton
Sponsor: University of New Brunswick

Sex: Female

Age: 19+

Code: NCT04679090

Recruiting

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

for
Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm,
Location: Houston TX
Sponsor: Lucid Lane, Inc

Sex: All

Age: 18+

Code: NCT04963972

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for
Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer,
Location: Houston TX, Beverly Hills CA, Santa Monica CA
Sponsor: Epkin

Sex: All

Age: 18+

Code: NCT06789172

Phase 1, Recruiting

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

for
Ovarian Cancer, Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05649072

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial